Clinical trial
Phase 1 Novel Topical Treatment for Post-herpetic Neuralgia
NCT00566904 is registered in ClinicalTrials.gov with Biomedical Development Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 Novel Topical Treatment for Post-herpetic Neuralgia
- Lead sponsor
- Biomedical Development Corporation
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- September 30, 2008
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
postherpetic neuralgia